cnxps.cmd.push(function () { cnxps({ playerId: '36af7c51-0caf-4741-9824-2c941fc6c17b' }).render('4c4d856e0e6f4e3d808bbc1715e132f6'); });
if(window.location.pathname.indexOf("647856") != -1) {console.log("hedva connatix");document.getElementsByClassName("divConnatix")[0].style.display ="none";}
The Pfizer-BioNTech candidate is seen my many as one of the most likely to win the vaccine race, with nations worldwide attempting to secure a means of ending the pandemic that has been raging since late 2019. Following their Phase III trial results revealed last Monday, the Israeli government has taken notice as well, with the government signing a formal contract Friday to receive eight million doses in January should it be successful.“This is a great day for the State of Israel and a great day on the way to our victory over the coronavirus,” Prime Minister Benjamin Netanyahu said on Friday. “Today we see a light at the end of the tunnel.”But other vaccine candidates look promising as well. One of these, US-based firm Moderna, is also confident its candidate will be just as good or better than its competitors, with its chief medical officer Tal Zaks explaining in late October that "Our vaccine creates antibodies in the body... which means that besides being a preventative vaccine, our product can also be used as treatment for people who've already been infected. We've shown that the product prevents the virus from replicating and improves the patient's condition." Likewise, Israel has also signed a deal with Moderna, and the Hadassah-University Medical Center in Jerusalem has signed an MOU with Russia to receive its Sputnik V vaccine candidate, which reportedly boasts an efficacy rate of 92%.Maayan Hoffman and Tobias Siegal contributed to this report.Article From & Read More ( BioNTech CEO: Our coronavirus vaccine can end the pandemic - The Jerusalem Post )
https://ift.tt/3kxK7hA
Business
Bagikan Berita Ini
0 Response to "BioNTech CEO: Our coronavirus vaccine can end the pandemic - The Jerusalem Post"
Post a Comment